Satoshi Yasuda
Japan Atomic Energy Agency
597 Papers
1.5K Citations
Satoshi Yasuda is an academic researcher from Japan Atomic Energy Agency. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 490 publications. Previous affiliations of Satoshi Yasuda include National Presto Industries & Hokkaido University.
Chat about Author
Papers
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Toshifumi Tada,Takashi Kumada,Atsushi Hiraoka,Kojiro Michitaka,Masanori Atsukawa,Masashi Hirooka,Kunihiko Tsuji,Toru Ishikawa,Koichi Takaguchi,Kazuya Kariyama,Ei Itobayashi,Kazuto Tajiri,Noritomo Shimada,Hiroshi Shibata,Hironori Ochi,Satoshi Yasuda,Hidenori Toyoda,Shinya Fukunishi,Hideko Ohama,Kazuhito Kawata,Shinichiro Nakamura,Kazuhiro Nouso,Akemi Tsutsui,Takuya Nagano,Norio Itokawa,Korenobu Hayama,Taeang Arai,Michitaka Imai,Kouji Joko,Yohei Koizumi,Yoichi Hiasa +30 more
TL;DR: The impact of NLR on associating outcomes in patients with HCC treated with lenvatinib is investigated.
Comparison of Mortality Prediction Models on Long-Term Mortality in Hospitalized Patients With Acute Heart Failure ― The Importance of Accounting for Nutritional Status ―
Hiroki Nakano,Kazunori Omote,Toshiyuki Nagai,Toshiyuki Nagai,Michikazu Nakai,Kunihiro Nishimura,Yasuyuki Honda,Satoshi Honda,Naotsugu Iwakami,Yasuo Sugano,Yasuhide Asaumi,Takeshi Aiba,Teruo Noguchi,Kengo Kusano,Hiroyuki Yokoyama,Satoshi Yasuda,Hisao Ogawa,Taishiro Chikamori,Toshihisa Anzai +18 more
TL;DR: The PROTECT 7-day model demonstrated the highest predictive performance for long-term as well as short-term mortality in AHF patients among the published MPMs, indicating the importance of accounting for nutritional status such as serum albumin and total cholesterol in AHf patients when developing a MPM.
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure
Atsushi Hiraoka,Takashi Kumada,Toshifumi Tada,Kazuya Kariyama,Joji Tani,Shinya Fukunishi,Masanori Atsukawa,Masashi Hirooka,Kunihiko Tsuji,Toru Ishikawa,Koichi Takaguchi,Ei Itobayashi,Kazuto Tajiri,Noritomo Shimada,Hiroshi Shibata,Hironori Ochi,Kazuhito Kawata,Satoshi Yasuda,Hidenori Toyoda,Hideko Ohama,Kazuhiro Nouso,Akemi Tsutsui,Takuya Nagano,Norio Itokawa,Korenobu Hayama,Taeang Arai,Michitaka Imai,Yohei Koizumi,Shinichiro Nakamura,Kouji Joko,Kojiro Michitaka,Yoichi Hiasa,Masatoshi Kudo +32 more
TL;DR: In this paper, the authors investigated the clinical role of continuing LEN beyond progression of disease (PD) in u-HCC patients and showed that LEN treatment beyond PD might be a good therapeutic option, at least until a more effective drug as a postprogression treatment after LEN failure is developed.
Clinical profiles and outcomes in the treatment of acute myocardial infarction in Japan of aging society
Makoto Suzuki,Kensaku Nishihira,Misa Takegami,Satoshi Honda,Sunao Kojima,Morimasa Takayama,Tetsuya Sumiyoshi,Hisao Ogawa,Kazuo Kimura,Satoshi Yasuda,Jamir Investigators +10 more
TL;DR: A risk-adapted allocation of invasive management therefore may have the potential of benefiting patients with non-ST-segment elevation AMI, in particular elders.
Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance
TL;DR: Diffuse coronary artery narrowing develops not only in patients with diabetes but also in those with IGT, and this morphological change is associated with postprandial hyperglycemia.